Home >

Top Features


Advertisement

Features

Jun 16, 2021
The latest research supports the use of adjuvant olaparib in patients with high-risk early-stage HER2-negative breast cancer and germline BRCA mutations.
Jun 11, 2021
Dr. Cox will be presented with the award at the 2021 ASCO Quality Care Symposium.

Exclusive Journals Coverage

Nov 16, 2020
In a special two-part series of articles published in JCO Global Oncology (JCO GO), experts take a closer look at oncology care and research in Africa. 
Jun 03, 2020
As oncologists evaluate early research on on COVID-19 and cancer care, Dr. Stephen A. Cannistra notes, the data and conclusions should be interpreted with caution at this stage.

Current Controversies in Oncology

Jul 17, 2018
The era of precision medicine in oncology offers promise for improved diagnosis and better therapy for patients with the CUP syndrome, and first steps have already been taken toward incorporating precision medicine into the routine management of disease in these patients. 
Apr 25, 2018
Drs. Sarah W. Gordon, Sarah M. Temkin, Debra L. Richardson, and Kathleen Moore debate the role of maintenance PARP in platinum-sensitive ovarian cancer.

ASCO International

May 28, 2021
The program combines virtual and in-person training sessions to help build leadership skills in managing teams, resolving conflict, coaching, communicating effectively with others, effectively presenting information, participating in and leading advocacy efforts, and more.
May 14, 2021
Dr. Ami S. Bhatt and Franklin W. Huang recognized the immense need for cancer care and research in the hardest-hit countries, which lacked the resources to care for patients with cancer. This need grew into the launch of their nonprofit organization, Global Oncology. 

Trainee & Early-Career Oncologists

May 03, 2021
With so many presentations and sessions at their fingertips, first-time attendees may be especially overwhelmed with where to start and how to build their schedule. Dr. Jamie H. Von Roenn has advice.
May 03, 2021
As Dr. Nancy U. Lin works to prevent breast cancer and uncover more treatment options, the two-time recipient of grants from Conquer Cancer is motivated by the patients who have contributed to her discoveries and the colleagues with whom she collaborates.